Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613001115729Phase 4Completed
Phase 4, randomised, double-blind trial of levobupivacaine, fentanyl and lidocaine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Gaziantep University. Primary endpoint: Total postoperative analgesic requirement over 24 hours. Started Mar 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613001115729.